[Electrocardiographic changes with the use of aminophylline and salbutamol in adult patients with chronic bronchial asthma].
Fifteen patients diagnosed with bronchial asthma were examined to evaluate the cardiotoxicity caused by the combined intravenous treatment using methylxanthine-aminophylline 250 mg and a beta agonist: salbutamol 0.5 mg. The following observations were made: four patients had sinus tachycardia and another suffered from ventricular extrasystoles as seen in the electrocardiographic register; another two patients had sinus tachycardia when the bronchial dilator dosage was doubled. From a clinical and electrocardiographic standpoint, arrhythmias do not seem to be a grave problem among the population studied.
Esquer Flores
J
J
Alergia e inmunología clínica, H.R. 20 de Noviembre, ISSSTE.
Orea Solano
M
M
Gálvez Gudiño
V J
VJ
D000328:Adult; D000420:Albuterol / Q000009:adverse effects*; D000628:Aminophylline / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000628:Aminophylline; D000420:Albuterol
Cambios electrocardiográficos con el uso de aminofilina y salbutamol en pacientes adultos con asma bronquial crónica.